These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4808861)

  • 21. Fluoranthenes: quantitative determination in cigarette smoke, formation by pyrolysis, and tumor-initiating activity.
    Hoffmann D; Rathkamp G; Nesnow S; Wynder EL
    J Natl Cancer Inst; 1972 Oct; 49(4):1165-75. PubMed ID: 5084125
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and tumor-initiating activities of dimethylchrysenes.
    Amin S; Balanikas G; Huie K; Hecht SS
    Chem Res Toxicol; 1988; 1(6):349-55. PubMed ID: 2979752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative tumorigenicity of dimethylchrysenes in mouse skin.
    Amin S; Desai D; Hecht SS
    Chem Res Toxicol; 1992; 5(2):237-41. PubMed ID: 1643253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene.
    Amin S; Juchatz A; Furuya K; Hecht SS
    Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
    Coombs MM; Dixon C; Kissonerghis AM
    Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological activity of some further cyclopenta[a]phenanthrenes.
    Bhatt TS
    Carcinogenesis; 1988 Sep; 9(9):1669-72. PubMed ID: 3409471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between carcinogenicity and chemical structure in cyclopenta(a)phenanthrenes.
    Coombs MM; Bhatt TS; Croft CJ
    Cancer Res; 1973 Apr; 33(4):832-7. PubMed ID: 4696480
    [No Abstract]   [Full Text] [Related]  

  • 29. Skin bioassays in tobacco carcinogenesis.
    Hoffmann D; Wynder EL; Rivenson A; LaVoie EJ; Hecht SS
    Prog Exp Tumor Res; 1983; 26():43-67. PubMed ID: 6844647
    [No Abstract]   [Full Text] [Related]  

  • 30. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition by a peri-fluorine atom of 1,2-dihydrodiol formation as a basis for the lower tumorigenicity of 12-fluoro-5-methylchrysene than of 5-methylchrysene.
    Amin S; Camanzo J; Hecht SS
    Cancer Res; 1984 Sep; 44(9):3772-8. PubMed ID: 6547637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumorigenicity of very fresh tobacco smoke condensate to mouse skin.
    Davies RF
    Br J Cancer; 1969 Dec; 23(4):858-60. PubMed ID: 5367345
    [No Abstract]   [Full Text] [Related]  

  • 33. Cocarcinogenesis studies on mouse skin and inhibition of tumor induction.
    Van Duuren BL; Blazej T; Goldschmidt BM; Katz C; Melchionne S; Sivak A
    J Natl Cancer Inst; 1971 May; 46(5):1039-44. PubMed ID: 5157842
    [No Abstract]   [Full Text] [Related]  

  • 34. The mouse skin carcinogenicity of cigarette smoke condensate: fractionated by solvent partition methods.
    Whitehead JK; Rothwell K
    Br J Cancer; 1969 Dec; 23(4):840-57. PubMed ID: 5367344
    [No Abstract]   [Full Text] [Related]  

  • 35. Short term test for evaluating potential carcinogenic activity of tobacco condensates.
    Healey P; Mawdesley-Thomas LE; Barry DH
    Nature; 1970 Dec; 228(5275):1006. PubMed ID: 5482099
    [No Abstract]   [Full Text] [Related]  

  • 36. Carcinogenicity of tobacco and tobacco smoke.
    Fisher RE
    Br Med J; 1968 Jan; 1(5586):253-4. PubMed ID: 5634829
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor-promoting activity of certain extracts of tobacco.
    Chortyk OT; Bock FG
    J Natl Cancer Inst; 1976 May; 56(5):1041-5. PubMed ID: 994196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioassays of carcinogenicity after fractionation of cigarette smoke condensate.
    Lazar P; Chouroulinkov I; Izard C; Moree-Testa P; Hemon D
    Biomedicine; 1974 May; 20(3):214-22. PubMed ID: 4433655
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of glycerol on local and systemic carcinogenicity of topically applied tobacco condensate.
    Wilson J; Clapp MJ; Conning DM
    Br J Cancer; 1978 Aug; 38(2):250-7. PubMed ID: 698039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the tumor initiating, tumor promoting, and tumor co-initiating properties of respiratory carcinogens.
    Nesnow S; Triplett LL; Slaga TJ
    Carcinog Compr Surv; 1985; 8():257-77. PubMed ID: 3986826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.